Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Current Applications of Staphylococcal Protein A in Biotechnology and Biomedicine: A Comprehensive Review.

Created on 21 Jul 2026

Authors

Shirin Damough, Shadi Damough, Ladan Mafakher, Masoumeh Heshmati, Ahmad Adeli, Yeganeh Talebkhan

Published in

Biotechnology and bioengineering. Jul 21, 2026. Epub Jul 21, 2026.

Abstract

Protein A (SpA), a cell wall-associated protein of Staphylococcus aureus, is an immunoglobulin (Ig) binding molecule with high affinity to the Fc moiety of IgG. It can help S. aureus for effective shielding from recognition and opsonization by immune cells, thereby promoting bacterial immune evasion. Since its recognition in the early 1980s, diverse applications have been developed across biotechnology, medicine, and biochemical research, using both native and recombinant SpA variants produced in various host cells. This review provides a comprehensive overview of the major applications of SpA, with an emphasis on techniques that progressed to commercially available tools/platforms. These applications are based on its Ig-binding capability, including purification of monoclonal antibodies in biopharmaceutical manufacturing, selective isolation of antibodies in diagnostic workflows, integration into serological assays or biosensor systems, and use as a fusion partner/tag for capturing recombinant proteins.

PMID:
42478320
Bibliographic data and abstract were imported from PubMed on 21 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement